Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adir Shaulov

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Leukemia & Lymphoma|January 29, 2019
Addition of high-dose methotrexate to standard treatment for patients with high-risk diffuse large B-cell lymphoma contributes to improved freedom from progression and survival but does not prevent central nervous system relapseNeta Goldschmidt, Netanel A Horowitz, Vered Heffes, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 12, 2018
Pain in patients with newly diagnosed or relapsed acute leukemiaAdir Shaulov, Gary Rodin, Gordana Popovic, et al.
Cancers|November 25, 2023
Standardization of Molecular MRD Levels in AML Using an Integral Vector Bearing ABL and the Mutation of InterestBoaz Nachmias, Svetlana Krichevsky, Moshe E Gatt, et al.
Leukemia & Lymphoma|October 16, 2025
First case report of talquetamab use in AL amyloidosisNoa Gross Even-Zohar, Shlomzion Aumann, Adir Shaulov, et al.
American Journal of Hematology|November 3, 2016
Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapyAdir Shaulov, Chezi Ganzel, Noam Benyamini, et al.
BMJ Supportive & Palliative Care|May 31, 2023
Interprofessional palliative and end-of-life education: short-term and long-term outcomes - mixed-methods analysisAdir Shaulov, Adi Finkelstein, Inon Vashdi, et al.
Leukemia Research|July 1, 2022
Re-induction versus salvage for D14-resiudal acute myeloid leukemia: A retrospective multi-center studyAvraham Frisch, Shlomzion Aumann, Tsila Zuckerman, et al.
Clinical and Experimental Immunology|June 11, 2021
Chronic demodicosis in patients with immune dysregulation: An unexpected infectious manifestation of Signal transducer and activator of transcription (STAT)1 gain-of-functionOded Shamriz, Atar Lev, Amos J Simon, et al.
European Journal of Haematology|May 31, 2023
Venetoclax-based salvage therapy for adult patients with relapsed/refractory acute lymphoblastic leukemiaJonathan Canaani, Avraham Frisch, Daniel A Pollyea, et al.
Anticancer Research|November 7, 2018
Hairy Cell Leukemia: Retrospective Analysis of Demographic Data and Outcome of 203 Patients from 12 Medical Centers in IsraelMichal Inbar, Yair Herishanu, Neta Goldschmidt, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Leukemia & Lymphoma|January 29, 2019
Addition of high-dose methotrexate to standard treatment for patients with high-risk diffuse large B-cell lymphoma contributes to improved freedom from progression and survival but does not prevent central nervous system relapseNeta Goldschmidt, Netanel A Horowitz, Vered Heffes, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 12, 2018
Pain in patients with newly diagnosed or relapsed acute leukemiaAdir Shaulov, Gary Rodin, Gordana Popovic, et al.
Cancers|November 25, 2023
Standardization of Molecular MRD Levels in AML Using an Integral Vector Bearing ABL and the Mutation of InterestBoaz Nachmias, Svetlana Krichevsky, Moshe E Gatt, et al.
Leukemia & Lymphoma|October 16, 2025
First case report of talquetamab use in AL amyloidosisNoa Gross Even-Zohar, Shlomzion Aumann, Adir Shaulov, et al.
American Journal of Hematology|November 3, 2016
Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapyAdir Shaulov, Chezi Ganzel, Noam Benyamini, et al.
BMJ Supportive & Palliative Care|May 31, 2023
Interprofessional palliative and end-of-life education: short-term and long-term outcomes - mixed-methods analysisAdir Shaulov, Adi Finkelstein, Inon Vashdi, et al.
Leukemia Research|July 1, 2022
Re-induction versus salvage for D14-resiudal acute myeloid leukemia: A retrospective multi-center studyAvraham Frisch, Shlomzion Aumann, Tsila Zuckerman, et al.
Clinical and Experimental Immunology|June 11, 2021
Chronic demodicosis in patients with immune dysregulation: An unexpected infectious manifestation of Signal transducer and activator of transcription (STAT)1 gain-of-functionOded Shamriz, Atar Lev, Amos J Simon, et al.
European Journal of Haematology|May 31, 2023
Venetoclax-based salvage therapy for adult patients with relapsed/refractory acute lymphoblastic leukemiaJonathan Canaani, Avraham Frisch, Daniel A Pollyea, et al.
Anticancer Research|November 7, 2018
Hairy Cell Leukemia: Retrospective Analysis of Demographic Data and Outcome of 203 Patients from 12 Medical Centers in IsraelMichal Inbar, Yair Herishanu, Neta Goldschmidt, et al.
Pageof 6